(Q41493938)

1 October 2017

title

Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors (English)

1 reference

1 October 2017

7

1 reference

1 October 2017

8

1 reference

1 October 2017

3

Alexander Muik

1 reference

1 October 2017

Robert C Münch

1

1 reference

1 October 2017

Anke Muth

2

1 reference

1 October 2017

Thorsten Friedel

4

1 reference

1 October 2017

Julia Schmatz

5

1 reference

1 October 2017

Birgit Dreier

6

1 reference

1 October 2017

Hildegard Büning

9

1 reference

1 October 2017

Christian J Buchholz

10

1 reference

1 October 2017

language of work or name

English

0 references

publication date

10 February 2015

1 reference

1 October 2017

published in

Nature Communications

1 reference

1 October 2017

volume

6

1 reference

1 October 2017

page(s)

6246

1 reference

1 October 2017

cites work

Gene therapy on the move

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Recent developments in adeno-associated virus vector technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Engineering adeno-associated viruses for clinical gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Selection and evaluation of clinically relevant AAV variants in a xenograft liver model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Development and validation of novel AAV2 random libraries displaying peptides of diverse lengths and at diverse capsid positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

High-affinity binders selected from designed ankyrin repeat protein libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

In vitro and in vivo effects of combination of Trastuzumab (Herceptin) and Tamoxifen in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

T-cell development and the CD4-CD8 lineage decision

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Current advances in humanized mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Unravelling cancer stem cell potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Rapid selection of high-affinity binders using ribosome display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Isolation of targeted AAV2 vectors from novel virus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Identification of a heparin-binding motif on adeno-associated virus type 2 capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Molecular analysis of circulating tumour cells-biology and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

DARPins: an efficient targeting domain for lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Specific gene delivery to liver sinusoidal and artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

Optimizing the adeno-associated viral vector system: a brief summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

7 January 2021

On the abundance of EpCAM on cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

7 January 2021

Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

7 January 2021

Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

7 January 2021

Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7246

7 January 2021

Identifiers

DOI

10.1038/NCOMMS7246

1 reference

1 October 2017

0 references

1 reference